ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
4,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
4,4,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
6,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
7,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
7,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
7,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Headache,Headaches NEC,Headaches,Nerv,N
11,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
13,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
14,1,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
15,1,Deafness,Hearing losses,Hearing disorders,Ear,N
16,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
16,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
17,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
18,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
18,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
19,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,1,Deafness,Hearing losses,Hearing disorders,Ear,N
22,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
23,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
24,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,2,Headache,Headaches NEC,Headaches,Nerv,N
25,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
26,5,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,Y
27,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
28,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
28,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
31,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
33,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
33,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,4,Neurological eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
33,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
34,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
35,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
36,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
37,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
37,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
37,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
37,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
37,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
37,6,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
38,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
38,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
40,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
40,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
41,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
41,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
42,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
43,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
44,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
44,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
44,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
45,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
46,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
48,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
49,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
50,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
52,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
52,2,Noninfective conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
53,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
53,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
53,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
53,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,1,Deafness,Hearing losses,Hearing disorders,Ear,N
55,1,Deafness,Hearing losses,Hearing disorders,Ear,N
56,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
57,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
58,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,5,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
59,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
59,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
59,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
59,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
59,6,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
59,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
59,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,9,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
59,10,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
59,11,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
59,12,Headache,Headaches NEC,Headaches,Nerv,N
59,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
60,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
60,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
60,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
60,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
61,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
61,4,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
62,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
62,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
62,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
62,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
62,6,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
62,7,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
62,8,Leukocyturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
62,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
62,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,11,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
63,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
63,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
64,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
64,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
64,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
64,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
64,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
65,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
65,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
65,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,6,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
65,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
66,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
66,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,4,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
66,5,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
67,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
67,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
68,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
69,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
69,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
70,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
70,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
70,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
70,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,8,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
70,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
70,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
70,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
71,1,Deafness,Hearing losses,Hearing disorders,Ear,N
72,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
73,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
73,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
73,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
74,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
74,2,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
75,1,Headache,Headaches NEC,Headaches,Nerv,N
76,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
78,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,1,Migraine,Migraine headaches,Headaches,Nerv,N
81,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
81,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
82,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
83,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
84,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
85,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
85,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
85,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
85,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,9,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
85,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
87,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
87,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
87,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
87,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
87,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
87,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
88,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
89,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
90,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
91,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
92,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
92,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
93,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
93,2,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
94,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
94,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
94,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
96,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
97,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
98,1,Burkholderia cepacia complex infection,Burkholderia infections,Bacterial infectious disorders,Infec,Y
98,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
98,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
99,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
100,1,Deafness,Hearing losses,Hearing disorders,Ear,N
101,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
102,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
103,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
103,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
104,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
105,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
106,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
106,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
107,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
108,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
108,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
109,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
109,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
109,3,Detached Descemet's membrane,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
109,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
110,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
110,2,Infective pulmonary exacerbation of cystic fibrosis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
111,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
111,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
111,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
111,6,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
111,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
111,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
111,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
111,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
111,11,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
111,12,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
112,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
112,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
113,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
113,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
114,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
114,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
115,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
116,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
116,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
117,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
117,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
117,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
117,4,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
117,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
117,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
117,8,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
117,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,10,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,12,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
117,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
117,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
117,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
117,16,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
117,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
117,18,Sputum retention,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
118,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
119,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
119,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
120,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
120,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
121,1,Deafness,Hearing losses,Hearing disorders,Ear,N
121,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
121,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
122,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
123,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
124,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
125,1,Deafness,Hearing losses,Hearing disorders,Ear,N
125,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
125,3,Headache,Headaches NEC,Headaches,Nerv,N
125,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
126,1,Deafness,Hearing losses,Hearing disorders,Ear,N
126,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
127,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
127,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
128,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,3,Headache,Headaches NEC,Headaches,Nerv,N
128,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,6,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
128,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
131,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
133,1,Deafness,Hearing losses,Hearing disorders,Ear,N
134,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
135,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
135,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
136,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
136,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
136,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
136,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
136,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
136,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
136,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
136,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
136,9,Pulpitis dental,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
136,10,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
137,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
138,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
138,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
138,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
138,4,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
138,5,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
138,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
138,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
138,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
138,10,Pulpitis dental,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
138,11,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
138,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
139,1,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
139,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
140,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
140,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
140,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
140,4,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
141,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
141,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
143,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
143,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
143,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,5,Headache,Headaches NEC,Headaches,Nerv,N
143,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
144,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
145,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
145,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
146,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
147,1,Vocal cord thickening,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
148,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
148,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
150,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
154,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
155,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
156,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
157,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
158,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
158,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
158,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
159,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
160,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
161,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
161,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
161,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
161,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
161,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
163,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
164,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
164,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
164,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
164,4,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
164,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
164,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
164,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
164,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
166,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
167,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
170,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
171,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
171,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
172,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
173,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
174,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
174,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
174,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
174,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
174,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
174,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
175,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
175,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
176,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
176,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
176,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
176,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
176,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
177,1,Bronchopulmonary aspergillosis allergic,Aspergillus infections,Fungal infectious disorders,Infec,N
177,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
178,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
179,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
179,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
179,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
179,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
179,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
179,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,10,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
179,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
180,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
180,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
180,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,5,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,7,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,8,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
180,9,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,11,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
180,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
181,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
182,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
183,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
183,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
183,3,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
183,4,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
183,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
183,6,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
184,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
185,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
185,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
185,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
185,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
185,5,Headache,Headaches NEC,Headaches,Nerv,N
185,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
185,7,Keratic precipitates,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
185,8,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
185,9,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
185,10,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
185,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
186,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
186,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
186,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,5,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
186,6,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
186,7,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
186,8,Anterior chamber inflammation,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
186,9,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
186,10,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
186,11,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
186,12,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
186,13,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,14,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,15,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
186,16,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
186,17,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,18,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,19,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,20,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
186,21,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
186,22,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
186,23,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
186,24,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
186,25,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
186,26,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
186,27,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
186,28,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
186,29,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
186,30,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,31,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,32,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,33,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
186,34,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
186,35,Headache,Headaches NEC,Headaches,Nerv,N
186,36,Headache,Headaches NEC,Headaches,Nerv,N
186,37,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
186,38,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
186,39,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
186,40,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
186,41,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
186,42,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
186,43,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
186,44,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
186,45,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
186,46,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
186,47,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
186,48,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
186,49,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
186,50,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
186,51,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
186,52,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
186,53,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
186,54,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
186,55,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
186,56,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
186,57,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
186,58,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
186,59,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
186,60,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
186,61,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
186,62,Uveitis-glaucoma-hyphaema syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
187,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
188,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,1,Headache,Headaches NEC,Headaches,Nerv,N
190,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
191,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
192,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
193,3,Lower respiratory tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
194,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
195,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
195,2,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
195,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
196,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
197,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
198,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
199,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
200,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
201,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
202,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
203,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
204,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
205,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
206,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
207,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
207,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
209,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
209,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
210,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
210,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
210,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
211,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
212,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
213,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
213,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
214,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
215,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
216,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
217,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
217,2,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
218,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
220,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
221,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
221,3,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
221,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
222,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
223,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
224,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
225,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
227,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
227,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
227,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,7,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
228,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
228,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
228,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
230,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
230,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
232,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
233,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
234,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
235,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
236,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
236,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
237,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
238,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
239,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
239,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
240,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
241,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
242,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
242,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
242,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
242,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
242,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
242,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
243,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
243,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
243,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
244,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
244,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
244,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
245,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
246,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
246,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
248,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
249,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
250,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
250,2,Deafness,Hearing losses,Hearing disorders,Ear,N
250,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
250,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
251,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
251,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
252,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
252,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
253,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
253,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
254,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
254,2,Deafness,Hearing losses,Hearing disorders,Ear,N
254,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
254,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
255,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
255,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
256,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
256,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
256,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
257,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
257,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
258,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
258,2,Deafness,Hearing losses,Hearing disorders,Ear,N
258,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
258,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
258,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
259,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
260,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
261,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
261,3,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
262,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
262,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
262,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
263,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
264,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
265,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
267,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
268,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
269,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
271,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
271,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
271,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
271,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
272,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
273,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
274,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
274,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
274,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
277,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
278,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
280,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
282,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
283,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
284,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
284,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
284,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
284,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
285,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
285,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
285,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
286,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
286,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
287,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
287,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
287,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
287,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
288,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
289,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
289,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
289,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
289,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
289,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
289,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
289,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
289,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
290,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
291,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
291,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
292,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
292,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
292,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
292,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
292,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
292,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
292,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
292,9,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
293,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
293,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
293,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
293,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
293,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
293,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
293,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
294,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
295,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
296,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
296,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
297,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
298,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
298,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
299,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
300,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
302,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
302,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
303,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
303,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
304,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
304,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
305,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
306,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
309,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
310,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
310,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
310,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
311,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
313,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
314,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
315,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
316,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
317,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
317,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
318,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
318,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
319,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
320,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
321,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
322,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
324,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
324,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
324,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
325,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
326,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
326,2,Fever neonatal,Febrile disorders,Body temperature conditions,Genrl,N
326,3,Hepatosplenomegaly neonatal,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
326,4,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
326,5,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
326,6,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
326,7,Pantoea agglomerans infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
326,8,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
326,9,Respiratory disorder neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
326,10,Thrombocytopenia neonatal,Thrombocytopenias,Platelet disorders,Blood,N
327,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
328,1,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
329,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
331,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
332,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
333,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
333,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
334,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
335,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
336,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
336,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
336,3,Headache,Headaches NEC,Headaches,Nerv,N
337,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
339,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
340,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
340,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
340,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
341,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
341,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
343,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
344,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
346,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
347,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
347,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
348,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
348,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
348,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
349,1,Headache,Headaches NEC,Headaches,Nerv,N
349,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
350,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
352,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
352,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
352,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
353,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
353,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
353,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
354,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
354,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
355,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
355,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
355,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
356,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
356,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
356,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
356,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
356,6,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
356,7,Tracheal pain,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
356,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
357,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
357,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
357,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
357,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
358,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
359,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
360,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
360,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
360,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
361,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
362,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
363,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
364,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
365,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
366,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
367,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
368,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
369,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
370,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
370,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
371,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
373,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
373,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
374,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
374,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
375,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
376,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
377,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
378,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
379,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
379,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
379,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
379,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
379,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
379,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
380,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
381,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
381,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
382,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
384,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
384,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
385,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
386,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
387,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
387,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
387,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
388,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
389,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
390,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
390,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
390,4,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
391,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
391,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
391,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
393,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
394,1,Bronchial secretion retention,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
394,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
394,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
394,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
394,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
395,1,Conjunctival disorder,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
395,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
395,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
395,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
395,5,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
395,6,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
395,7,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
395,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
396,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
397,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
397,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
400,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
402,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
403,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
404,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
405,1,Deafness,Hearing losses,Hearing disorders,Ear,N
406,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
406,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
407,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
407,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
408,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
409,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
410,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
412,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
412,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
412,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
412,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
412,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
412,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
413,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
414,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
414,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
415,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
416,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
417,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
418,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
419,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
419,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
419,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
420,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
421,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
421,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
421,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
421,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
422,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
423,1,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
424,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
424,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
424,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
424,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
425,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
426,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
427,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
428,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
429,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
430,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
430,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
431,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
432,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
432,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
433,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
434,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
434,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
434,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
436,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
436,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
437,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
437,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
438,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
438,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
439,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
440,1,Infusion site irritation,Infusion site reactions,Administration site reactions,Genrl,N
441,1,Disability,Disability issues,Lifestyle issues,SocCi,N
441,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
442,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
442,2,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
443,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
444,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
445,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
447,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
447,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
448,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
449,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
449,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
449,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
450,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
452,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
453,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
454,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
456,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
456,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
457,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
457,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
457,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
457,4,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
458,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
459,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
460,1,Infective pulmonary exacerbation of cystic fibrosis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
460,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
461,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
461,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
462,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
462,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
462,4,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
462,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
463,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
463,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
464,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
464,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
465,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
466,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
467,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
468,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
469,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
469,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
470,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
470,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
470,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
471,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
472,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
472,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
473,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
473,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
473,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
474,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
475,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
475,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
476,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
477,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
477,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
477,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
477,4,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
477,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
478,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
479,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
479,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
480,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
480,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
480,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
481,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
